Thaarvena Retinasamy

Bandar, 47500, Malaysia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Exploring the role of tocotrienol-rich fraction (TRF) in ameliorating neuroinflammation.

Exploring the role of tocotrienol-rich fraction (TRF) in ameliorating neuroinflammation.

Journal: Inflammopharmacology

Published: March 12, 2026

Modulation of NF-κB signaling pathway by tocotrienol in neurodegenerative diseases.

Modulation of NF-κB signaling pathway by tocotrienol in neurodegenerative diseases.

Journal: Discover mental health

Published: February 13, 2025

Repurposing Anakinra for Alzheimer's Disease: The In Vitro and In Vivo Effects of Anakinra on LPS- and AC-Induced Neuroinflammation.

Repurposing Anakinra for Alzheimer's Disease: The In Vitro and In Vivo Effects of Anakinra on LPS- and AC-Induced Neuroinflammation.

Journal: ACS chemical neuroscience

Published: August 30, 2024

The Role of HMGB1 in Infection-Related Cognitive Deficits.

The Role of HMGB1 in Infection-Related Cognitive Deficits.

Journal: Frontiers in bioscience (Landmark edition)

Published: July 04, 2024

High Mobility Group Box-1 (HMGB1), a Key Mediator of Cognitive Decline in Neurotrauma with a Potential for Targeted Therapy: A Comprehensive Review.

High Mobility Group Box-1 (HMGB1), a Key Mediator of Cognitive Decline in Neurotrauma with a Potential for Targeted Therapy: A Comprehensive Review.

Journal: Frontiers in bioscience (Landmark edition)

Published: May 15, 2024

An Expanded Narrative Review of Neurotransmitters on Alzheimer's Disease: The Role of Therapeutic Interventions on Neurotransmission.

An Expanded Narrative Review of Neurotransmitters on Alzheimer's Disease: The Role of Therapeutic Interventions on Neurotransmission.

Journal: Molecular neurobiology

Published: July 06, 2023

Neuroinflammation: A Common Pathway in Alzheimer's Disease and Epilepsy.

Neuroinflammation: A Common Pathway in Alzheimer's Disease and Epilepsy.

Journal: Journal of Alzheimer's disease : JAD

Published: April 24, 2023

Neuroprotective potency of mangiferin against 3-nitropropionic acid induced Huntington's disease-like symptoms in rats: possible antioxidant and anti-inflammatory mechanisms.

Neuroprotective potency of mangiferin against 3-nitropropionic acid induced Huntington's disease-like symptoms in rats: possible antioxidant and anti-inflammatory mechanisms.

Journal: Frontiers in pharmacology

Published: March 20, 2023

The Role of Interferon-α in Neurodegenerative Diseases: A Systematic Review.

The Role of Interferon-α in Neurodegenerative Diseases: A Systematic Review.

Journal: Journal of Alzheimer's disease : JAD

Published: February 13, 2023

Regulation of gut microbiome by ketogenic diet in neurodegenerative diseases: A molecular crosstalk.

Regulation of gut microbiome by ketogenic diet in neurodegenerative diseases: A molecular crosstalk.

Journal: Frontiers in aging neuroscience

Published: August 10, 2022

Is Aducanumab for LMICs? Promises and Challenges.

Is Aducanumab for LMICs? Promises and Challenges.

Journal: Brain sciences

Published: September 29, 2021

The Role of High Mobility Group Box 1 (HMGB1) in Neurodegeneration: A Systematic Review.

The Role of High Mobility Group Box 1 (HMGB1) in Neurodegeneration: A Systematic Review.

Journal: Current neuropharmacology

Published: September 20, 2021

Showing 1-12 of 14

Last Updated: 09/26/2026